Eli Lilly and Company has promoted Johna Norton to senior vice president (SVP) of global quality, effective on April 1, 2017, following the retirement of the current SVP of global quality, Fionnuala Walsh, PhD, on April 15, 2017. Ms. Norton currently serves as vice president, global quality for active pharmaceutical ingredient (API) manufacturing, product research and development.
Ms. Norton joined Lilly in 1990 as an analytical chemist and has subsequently held various positions in quality assurance and quality control supporting manufacturing and process development at Lilly facilities and with Lilly external manufacturing partners. In 2012, she assumed her current responsibilities for providing quality oversight and direction for Lilly's API Manufacturing network and the product research and development organization.
Dr. Walsh joined Lilly's Kinsale, Ireland, manufacturing site in 1988 as a technical services chemist. After numerous positions there, she moved into a role as global quality leader at the Lilly corporate center in Indianapolis in 2002. In January 2003, Dr. Walsh was named executive director of quality for US drug product and Lilly technology center operations. In July 2005, she was named vice president of global quality operations and, in June 2007, was named SVP of global quality. She joined the executive committee in 2009.
In addition to Dr. Walsh’s retirement, Bart Peterson, SVP of corporate affairs and communications, will leave Lilly on March 31, 2017. Mr. Peterson joined Lilly in 2009. A search currently is under way for his replacement.
Mr. Peterson served as managing director of Strategic Capital Partners, as a fellow with the Institute of Politics at Harvard University's Kennedy School of Government, and as a distinguished visiting professor of public policy at Ball State University before joining Lilly in 2009. From 2000 to 2007, he served as mayor of Indianapolis.
Source: Eli Lilly and Company